Open AccessProgression of the tumor in a patient with a gastrointestinal stromal tumor with the PDGFRA exon 12 mutation who received multiple surgeries and multiple lines of tyrosine kinase inhibitor therapies: a case report
Author(s) -
Zhaojie An,
Ming Tan,
Yuxiang Xia,
Yong Li,
Liqiao Fan,
Qun Zhao,
Zhidong Zhang,
Bibo Tan,
Yu Liu,
Zhixue Ma,
Dong Wang,
Xüe-Feng Zhao
Publication year - 2022
Publication title -
journal of gastrointestinal oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.084
H-Index - 39
eISSN - 2219-679X
pISSN - 2078-6891
DOI - 10.21037/jgo-22-791
Subject(s) - pdgfra , medicine , sunitinib , stromal tumor , gist , regorafenib , imatinib , exon , tyrosine kinase inhibitor , tyrosine kinase , targeted therapy , oncology , cancer research , imatinib mesylate , pathology , stromal cell , cancer , colorectal cancer , receptor , myeloid leukemia , chemistry , biochemistry , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom